Company news

Processa Pharmaceuticals, Inc. news in 2021

Processa Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Processa Pharmaceuticals Announces Third Quarter 2021 Results and Provides Corporate Update

November 10, 2021

Processa Pharmaceuticals Announces Next Generation Capecitabine (Combination of PCS6422 and Capecitabine) Inhibits DPD in Phase 1b Interim Analysis

November 3, 2021

Processa Pharmaceuticals Schedules Conference Call to Discuss Third Quarter Results and Provide Drug Development Update on November 11 at 5: 30 p.m. EST

October 25, 2021

Processa Pharmaceuticals Cleared by FDA to Proceed with Phase 2a Trial for the Treatment of Gastroparesis

October 11, 2021

Processa Pharmaceuticals Announces Second Quarter 2021 Results and Provides Corporate Update

August 11, 2021

Processa Pharmaceuticals Schedules Conference Call to Discuss Second Quarter Results and Provide Drug Development Update on August 12 at 5: 30 p.m. EST

August 5, 2021

Processa Announces First Patient Dosed in PCS6422 Study in Gastrointestinal Cancer

August 3, 2021

Processa Pharmaceuticals enters into a licensing agreement with Ocuphire Pharma, Inc., for the development of RX-3117

June 16, 2021

Processa Set to Join Russell Microcap® Index

June 7, 2021

Processa Pharmaceuticals Announces First Patient Dosed in its Randomized Double-Blind, Placebo-Controlled Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica

May 19, 2021

Processa Pharmaceuticals Announces First Quarter 2021 Results and Provides Corporate Update

May 12, 2021

Processa Pharmaceuticals Announces Year end 2020 Results and Provides Corporate Update

March 24, 2021

Processa Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter Results and Provide Drug Development Update on March 25 at 5: 30 p.m. ET

March 21, 2021

Processa Announces Sites Selected for Phase 2B Clinical Trial to Treat Patients with Ulcerated Necrobiosis Lipoidica

March 16, 2021

Processa Pharmaceuticals Announces Closing of a $10.2 Million Private Placement

March 1, 2021

Processa Pharmaceuticals Announces $10.2 Million Strategic Financing

February 16, 2021

Calls in 2021

Decks in 2021